Asset Details
Do you wish to reserve the book?
Preliminary Results of a Trial of Atabecestat in Preclinical Alzheimer’s Disease
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Preliminary Results of a Trial of Atabecestat in Preclinical Alzheimer’s Disease
Do you wish to request the book?
Preliminary Results of a Trial of Atabecestat in Preclinical Alzheimer’s Disease
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Preliminary Results of a Trial of Atabecestat in Preclinical Alzheimer’s Disease
2019
Overview
A preliminary analysis of a trial involving participants with brain amyloid deposition who are at risk for dementia due to Alzheimer’s disease showed no benefit of a β-secretase enzyme inhibitor over placebo and a potential signal of worse cognitive test scores over 3 and 6 months.
Publisher
Massachusetts Medical Society
Subject
